Skip to main content

My Company - Recce Pharmaceuticals

The company I have been given to base my assignment tasks on for the ACCT11059 unit is Recce (pronounced Re-Key) Pharmaceuticals.  So who are they and what do they do?



Australia's Recce Pharmaceuticals is a biotechnology business dedicated to creating an innovative class of synthetic antibiotics. The company's main product, RECCE 327, is well-known for its ability to specifically target and eradicate bacteria, including types resistant to antibiotics. With a distinct mode of action, Recce's anti-infectives aim to provide doctors with a therapeutic tool that works against a variety of germs and may be used time and time again.

A fast-acting, broad-spectrum antibiotic, RECCE® 327 is efficient against both Gram-positive and Gram-negative bacteria, including superbugs that are resistant to antibiotics.  For oral usage, RECCE® 435 is a synthetic polymer antibiotic with a broad spectrum of activity.  RECCE® 529 is an anti-infective synthetic polymer that targets viral indications in accordance with Recce's prior antiviral research. The following information clip was taken from Recce's website to help you better understand what they do.


To view to-date share prices for Recce Pharmaceuticals -   Recce Share Price at the time of writing this blog the share price was ASX: RCE $0.435

To further explore this company go to their website https://www.recce.com.au/ I am sure you will find it very interesting as I did.  

Be sure to keep updated through my blog as I continue to unwrap the What, Why and How of this company.

Comments

Post a Comment

Popular posts from this blog

Assessment Task 2 - Steps 1-5 - Draft for Feedback

Below is my first draft for Assessment Task 2.  I am yet to complete Step 5 - giving feedback and will update this post once this step is completed.  I look forward to receiving your feedback   Step 1: KCQS Chapters 6 – 8 When I read Chapter 6, "Understanding Key Cost Relationships," I quickly learned about several types of cost behaviours, including fixed, variable, and mixed costs. The chapter emphasised the importance of understanding cost-volume-profit analysis and how it may help organisations make well-informed decisions about sales, production, and pricing. It was especially fascinating to investigate the complex relationships between the volume of production and the total cost and profit of a good or service. KCQs from Chapter 6: 1.      What kinds of cost behaviours were covered in Chapter Six? Chapter six covers key ideas including fixed costs, variable costs, and mixed costs as it examines various cost behaviours. It is an essential ...
Post a Comment
Read more

Assignment Task 1 - Step 1 - KCQs for Introduction & Chapter 1

As I embark on my journey into the subject of accounting, I must admit that I am experiencing a range of emotions about this unit. I feel a mix of excitement and readiness to delve deeper into the accounting field, coupled with nervousness about studying the subject. In addition, there is an unease that not having enough motivation could result in me not completing this unit successfully. I understand that many others probably experience similar concerns and doubts when navigating the complexities of accounting, so I might not be the only one going through this. The fact that this is an introductory accounting course is a positive, nonetheless. It is comforting to know that this is an opportunity to learn the fundamentals rather than an extremely difficult undertaking. After reading the Introduction and Chapter 1 of the Study Guide, numerous thoughts are running through my head. The prospect of being assigned my own listed company to work on throughout the unit is exciting, and I eager...
Post a Comment
Read more

Recce Pharmaceuticals - In the News

While researching Recce Pharmaceuticals and getting to know who they are I came across the following articles, clips and media that I found interesting and wanted to share. https://themarketherald.com.au/recce-pharmaceuticals-raise-to-progress-advanced-anti-infective-2023-10-09/ https://www.edisongroup.com/edison-tv/recce-pharmaceuticals-executive-interview/30782/
Post a Comment
Read more